Laboratorio Farmaceutico Erfo SpA (FRA:RK7) COGS-to-Revenue : 0.59 (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Laboratorio Farmaceutico Erfo SpA COGS-to-Revenue?

Laboratorio Farmaceutico Erfo SpA's Cost of Goods Sold for the six months ended in Dec. 2024 was €1.69 Mil. Its Revenue for the six months ended in Dec. 2024 was €2.89 Mil.

Laboratorio Farmaceutico Erfo SpA's COGS to Revenue for the six months ended in Dec. 2024 was 0.59.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Laboratorio Farmaceutico Erfo SpA's Gross Margin % for the six months ended in Dec. 2024 was 41.30%.

Laboratorio Farmaceutico Erfo SpA COGS-to-Revenue Historical Data

The historical data trend for Laboratorio Farmaceutico Erfo SpA's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorio Farmaceutico Erfo SpA COGS-to-Revenue Chart

Laboratorio Farmaceutico Erfo SpA Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.26

0.46

0.49

0.58

Laboratorio Farmaceutico Erfo SpA Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
COGS-to-Revenue	Get a 7-Day Free Trial					0.53	0.55	0.62	0.57	0.59

Laboratorio Farmaceutico Erfo SpA COGS-to-Revenue Calculation

Laboratorio Farmaceutico Erfo SpA's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	3.494	/	6.032
	=	0.58

Laboratorio Farmaceutico Erfo SpA's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1.694	/	2.886
	=	0.59

Laboratorio Farmaceutico Erfo SpA (FRA:RK7) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Laboratorio Farmaceutico Erfo SpA's Gross Margin % for the six months ended in Dec. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	1.694 / 2.886
	=	41.30 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Laboratorio Farmaceutico Erfo SpA COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Laboratorio Farmaceutico Erfo SpA's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Laboratorio Farmaceutico Erfo SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Laboratorio Farmaceutico Erfo SpA (FRA:RK7) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

ERFO:Italy

Address

Viale Geki Russo Lo. Pontegallo, Villafranca Tirrena, Messina, ITA, 98049

Website

https://www.erfo.it

Laboratorio Farmaceutico Erfo SpA operates in the nutraceutical sector. The company specializes in formulating and producing food supplements and natural medicines in different forms such as liquids, powders, granules, tablets, and soft gels. Geographically, the company generates a majority of its revenue from Italy followed by Spain, France, Belgium, and other countries.

Laboratorio Farmaceutico Erfo SpA Headlines

No Headlines